FEKFX | VIVIX | FEKFX / VIVIX | |
Total Expense Ratio | 0.34 | 0.04 | 850% |
Annual Report Gross Expense Ratio | 0.34 | 0.04 | 850% |
Fund Existence | 6 years | 27 years | - |
Gain YTD | 11.439 | 6.730 | 170% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 268M | 195B | 0% |
Annual Yield % from dividends | 1.64 | 2.19 | 75% |
Returns for 1 year | 14.00 | 9.75 | 144% |
Returns for 3 years | 47.11 | 34.32 | 137% |
Returns for 5 years | 91.55 | 74.87 | 122% |
Returns for 10 years | N/A | 116.26 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JSEZX | 39.93 | 0.39 | +0.99% |
JPMorgan Small Cap Equity R2 | |||
FACSX | 52.88 | 0.45 | +0.86% |
Nuveen Mid Cap Value Opportunities C | |||
ICVPX | 15.80 | 0.12 | +0.77% |
VY® Columbia Small Cap Value II S2 | |||
GCMUX | 38.89 | 0.25 | +0.65% |
Goldman Sachs Mid Cap Value R6 | |||
RLLGX | 76.82 | 0.38 | +0.50% |
American Funds SMALLCAP World R6 |